Deal Library / Pharma BD Deal Intelligence

F. Hoffmann-La Roche AG — Pharma Deals

The Pharma Closeout tracks 7 deals, $22.0B in disclosed deal value, 1 with a post-close Outcome Score for F. Hoffmann-La Roche AG.

Median Critic Score: 78  ·  Median Outcome Score: 20

All 7 deals

• F. Hoffmann-La Roche AG / Tensha Therapeutics, Inc. — 2016 · $535M · Did not work — the deal failed to deliver.
• F. Hoffmann-La Roche AG / MediLink Therapeutics (Suzhou) Co., Ltd. — 2026 · $570M
• F. Hoffmann-La Roche AG / Hansoh Pharmaceutical Group Co. Ltd. — 2026 · $15.5B
• F. Hoffmann-La Roche AG / Manifold Bio, Inc. — 2025 · $2.0B
• F. Hoffmann-La Roche AG / Qyuns Therapeutics Co., Ltd. — 2025 · $1.1B
• F. Hoffmann-La Roche AG / Hansoh Pharmaceutical Group Co. Ltd. — 2025 · $1.5B
• F. Hoffmann-La Roche AG / Ionis Pharmaceuticals, Inc. — 2023 · $760M

← Deal Library  ·  Interactive search  ·  How we score deals